Skip to content
Trial Eligibility
Menu

A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers

NCT07159282

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

A multicenter, prospective, controlled clinical trial evaluating the efficacy of a single layer placental-based allograft and standard of care in the management of nonhealing diabetic foot ulcers.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Diabetic Foot
  • Foot Ulcer
  • Ulcer Foot
  • DFU
  • Foot Ulcer Due to Type 2 Diabetes Mellitus
  • Foot Ulcer Due to Type 1 Diabetes Mellitus
  • Diabetic Foot Ulcer

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Applied Biologics, LLC
Last updated on ClinicalTrials.gov
February 11, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Florida · 1

  • Royal Research · Hollywood, FL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.